Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Relypsa Inc (NASDAQ:RLYP)

33.11
Delayed Data
As of Jul 31
 -0.63 / -1.87%
Today’s Change
17.60
Today|||52-Week Range
42.26
+7.50%
Year-to-Date
No recent news for Relypsa Inc.

Today’s Trading

Previous close33.74
Today’s open33.94
Day’s range33.04 - 34.24
Volume466,783
Average volume (3 months)418,638
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+10.99%
Earnings growth (this year)-88.15%
Earnings growth (next 5 years)+21.09%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book9.80

Competitors

 Today’s
change
Today’s
% change
ESPREsperion Therapeutic...-2.25-3.50%
AXONAxovant Sciences Ltd-0.59-4.04%
CHRSCoherus Biosciences ...+1.36+4.03%
MNTAMomenta Pharmaceutic...-0.01-0.05%
Data as of 4:01pm ET, 07/31/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)-$1.00
Annual revenue (last year)$0.00
Annual profit (last year)-$79.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John A. Orwin
Senior Vice President-
Pharmaceutical Operations
Wilhelm Stahl
Corporate headquarters
Redwood City, California

Forecasts